Evaluation of the confidential unit exclusion form: The Canadian Blood Services experience

Vox Sanguinis

Volumn 98, Issue 2, 2010, Pages 138-144

  O'Brien, S F ^a,b   Fan, W ^a   Xi, G ^a   Yi, Q L ^a,b   Goldman, M ^a,c  

^a CANADIAN BLOOD SERVICES   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Blood safety; Confidential unit exclusion; Donor risk factors

Indexed keywords

ARTICLE; BLOOD SAMPLING; CANADA; CONFIDENTIAL UNIT EXCLUSION; CONTROLLED STUDY; HEALTH CARE UTILIZATION; HEALTH SERVICE; HEALTH SURVEY; HEPATITIS C VIRUS; HIGH RISK BEHAVIOR; HUMAN; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS; PATIENT SAFETY; PRIORITY JOURNAL; RISK ASSESSMENT; BLOOD; BLOOD DONOR; BLOOD TRANSFUSION; BLOODBORNE BACTERIUM; CONFIDENTIALITY; DISEASE TRANSMISSION; HEPATITIS C; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; PREVENTION AND CONTROL; RISK FACTOR; STANDARDS;

BLOOD DONORS; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; CANADA; CONFIDENTIALITY; DATA COLLECTION; DISEASE TRANSMISSION, INFECTIOUS; HEPATITIS C; HIV INFECTIONS; HUMANS; RISK FACTORS;

EID: 74549184535     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2009.01236.x     Document Type: Article

References (19)

1. Pindyck J., Waldman A, Zang E, Oleszko W, Lowy M, Bianco C : Measures to decrease the risk of acquired immunodeficiency syndrome transmission by blood transfusion. Transfusion 1985 25 : 3 9.
2. Nusbacher J, Chiavetta J, Naiman R, Buchner B, Scalia V, Herst R : Evaluation of a confidential method of excluding blood donors exposed to human immunodeficiency virus. Transfusion 1986 26 : 539 541.
3. Nusbacher J, Chiavetta J, Naiman R, Buchner B, Reeves J, Scalia V, Herst R : Evaluation of a confidential method of excluding blood donors exposed to human immunodeficiency virus: studies on hepatitis and cytomegalovirus markers. Transfusion 1987 27 : 207 209.
4. Chiavetta JA, Nusbacher J, Wall A : Donor self-exclusion patterns and human immunodeficiency virus antibody test results over a twelve-month period. Transfusion 1989 29 : 81 83.
5. Petersen LR, Lackritz E, Lewis WF, Smith DS, Herrera G, Raimondi V, Aberle-Grasse J, Dodd RY : The effectiveness of the confidential unit exclusion option. Transfusion 1994 34 : 865 869.
6. US Food and Drug Administration. Revised Recommendations for the Prevention of Human Immunodeficiency Virus (HIV) Transmission by Blood and Blood Products. Bethesda, MD, US Food and Drug Administration, 1992.
7. Zou S, Notari EP IV, Musavi F, Dodd RY, for the ARCNET Study Group : Current impact of the confidential unit exclusion option. Transfusion 2004 44 : 651 657.
8. Canadian Public Health Agency of Canada (PHAC) : Available at: http://www.phac-aspc.gc.ca/aids-sida/publication/index-eng.php#surveillance (Accessed 21 August, 2009).
9. Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S, Hone D, O'Brien SF, Sher G : Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. CMAJ 2003 169 : 767 773.
10. O'Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vamvakas EC : Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services. Transfusion 2007 47 : 316 325.
11. O'Brien SF, Xi G, Fan W, Yi QL, Fearon MA, Scalia V, Goldman M : Epidemiology of hepatitis B in Canadian blood donors. Transfusion 2008 48 : 2323 2330.
12. O'Brien SF, Fan W, Xi G, Yi QL, Goldman M, Fearon MA, Infante-Rivard C, Chiavetta JA, Willems B, Pi D, Fast M, Delage G : Declining hepatitis C rates in first time blood donors: insight from surveillance and case-control risk factor studies. Transfusion 2008 48 : 902 909.
13. Kean CA, Hsueh Y, Querin JJ, Keating LJ, Allensworth DD : A study of confidential unit exclusion. Transfusion 1990 30 : 707 709.
14. Korelitz JJ, Williams AE, Busch MP, Zuck TF, Ownby HE, Matijas LJ, Wright DJ : Demographic characteristics and prevalence of serologic markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor Study. Transfusion 1994 34 : 870 876.
15. O'Brien SF, Ram SS, Yi QL, Goldman M : Donor's understanding of the definition of sex as applied to predonation screening questions. Vox Sang 2008 94 : 329 333.
16. Franklin IM : Is there a right to donate blood? Patient rights; donor responsibilities Transfus Med 2007 17 : 161 168.
17. Roehr B, Brooks JP : Should men who have ever had sex with men be allowed to give blood? BMJ 2009 338 : 572 573.
18. Williams AE, Thomson RA, Schreiber GB, Watanabe K, Bethel J, Lo A, Kleinman SH, Hollingsworth CG, Nemo GJ, for the Retrovirus epidemiology donor study : Estimates of infectious disease risk factors in US blood donors. JAMA 1997 277 : 967 972.
19. Domen RE : The confidential unit exclusion and allogeneic blood donation. Results from supplementary questions to the donor center and viral markers surveys of the College of American Pathologists. Arch Pathol Lab Med 1995 119 : 1007 1011.